These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4670447)

  • 21. [Treatment of myocardial infarct with anticoagulants, thrombolytics, inhibitors of platelet aggregation and beta receptor blockaders].
    Thiele R
    Z Arztl Fortbild (Jena); 1984; 78(5):167-71. PubMed ID: 6202068
    [No Abstract]   [Full Text] [Related]  

  • 22. Fifty years of experience with antithrombotic therapy in cardiac disease. A 1996 approach based on pathogenesis and risk.
    Freudenberger RS; Fuster V
    Mt Sinai J Med; 1996; 63(5-6):342-58. PubMed ID: 8898540
    [No Abstract]   [Full Text] [Related]  

  • 23. Characterisation of a novel series of aprotinin-derived anticoagulants. II. Comparative antithrombotic effects on primary thrombus formation in vivo.
    Stassen JM; Lambeir AM; Vreys I; Deckmyn H; Matthyssens G; Nyström A; Vermylen J
    Thromb Haemost; 1995 Aug; 74(2):655-9. PubMed ID: 8585002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in medicine.
    McNicol GP; Davies JA
    Practitioner; 1972 Oct; 209(252):411-23. PubMed ID: 4562341
    [No Abstract]   [Full Text] [Related]  

  • 25. [Analysis of the effectiveness of anticoagulant and fibrinolytic therapy in myocardial infarct].
    Kheĭnonen IM; Makeeva GK; Kholodilina IM
    Klin Med (Mosk); 1969 Jul; 47(7):41-8. PubMed ID: 5385087
    [No Abstract]   [Full Text] [Related]  

  • 26. Evolving antithrombotic treatment strategies for acute ST-elevation myocardial infarction.
    Kandzari DE
    Rev Cardiovasc Med; 2006; 7 Suppl 4():S29-37. PubMed ID: 17224888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of platelet adhesion and aggregation in antithrombotic therapy.
    Ruggeri ZM
    West J Med; 1993 Dec; 159(6):702-4. PubMed ID: 8128694
    [No Abstract]   [Full Text] [Related]  

  • 28. [Certain aspects of the tactics of anticoagulant therapy in myocardial infarct].
    Anisimov VK
    Ter Arkh; 1969 Apr; 41(4):94-9. PubMed ID: 5379418
    [No Abstract]   [Full Text] [Related]  

  • 29. Thrombosis: its role and prevention in cardiovascular events-Part II.
    Harker LA; Thompson AR; Harlan JM
    West J Med; 1981 Apr; 134(4):315-32. PubMed ID: 7018088
    [No Abstract]   [Full Text] [Related]  

  • 30. Drugs for the prevention of myocardial infarction.
    Hampton JR; Gorlin R
    Am J Med Sci; 1969 Jul; 258(1):1-6. PubMed ID: 5797290
    [No Abstract]   [Full Text] [Related]  

  • 31. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
    Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
    Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do interventions provide additional benefit to drug treatment of acute coronary syndromes? A call for a reserved, watchful approach.
    Gulba DC
    Thromb Haemost; 1999 Aug; 82(2):953-61. PubMed ID: 10605809
    [No Abstract]   [Full Text] [Related]  

  • 33. Fibrinolysis for acute myocardial infarction: the future is here and now.
    Armstrong PW; Collen D; Antman E
    Circulation; 2003 May; 107(20):2533-7. PubMed ID: 12777317
    [No Abstract]   [Full Text] [Related]  

  • 34. Reduced tissue factor pathway inhibitor-1 after pharmacological thrombolysis: an epiphenomenon or potential culprit in rethrombosis?
    Shah PK
    Circulation; 2002 Jan; 105(3):270-1. PubMed ID: 11804975
    [No Abstract]   [Full Text] [Related]  

  • 35. [Thrombolytic therapy].
    Schmutzler R; Koller F
    Ergeb Inn Med Kinderheilkd; 1965; 22():157-210. PubMed ID: 5889464
    [No Abstract]   [Full Text] [Related]  

  • 36. The role of platelets and platelet inhibition in acute myocardial infarction.
    Valettas N; Herrmann HC
    Coron Artery Dis; 2003 Aug; 14(5):357-63. PubMed ID: 12878900
    [No Abstract]   [Full Text] [Related]  

  • 37. [The place of fibrinolytic and antiplatelet-aggregation agents in therapy].
    Griguer RP; Brochier M; Raynaud R
    Ann Cardiol Angeiol (Paris); 1973; 22(6):461-72. PubMed ID: 4772262
    [No Abstract]   [Full Text] [Related]  

  • 38. [Anticoagulant therapy in acute myocardial infarct. Therapeutic indications based on incomplete experimental data].
    Goldman L
    Recenti Prog Med; 1980 Apr; 68(4):382-93. PubMed ID: 6992245
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of angina pectoris and myocardial infarct].
    Teicher H
    Ther Ggw; 1967 May; 106(5):591-2 passim. PubMed ID: 5622740
    [No Abstract]   [Full Text] [Related]  

  • 40. [Antiplatelets and anticoagulants in acute coronary syndromes: levels of evidence].
    Páramo JA; García R; Rodríguez P; de Gaona ER
    Rev Med Univ Navarra; 2007; 51(1):23-7. PubMed ID: 17555117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.